Skip to main content
OpenTrials
Completed

NCT Number: NCT02035280

Prospective Evaluation of Elderly Deformity Surgery

As the population continues to age, the prevalence of spinal deformity surgery for older patients is increasing. Questions regarding the suitability of these patients to undergo large spinal procedures and whether the outcomes merit the risks involved are not well known.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adult Spinal Deformity Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Toronto Western Hospital, Toronto, Ontario, Canada

Loading trial locations.

About this study

225 subjects greater than or equal 60 years of age with moderate and severe adult spinal deformity requiring surgical correction will be enrolled in a prospective multicenter international study. Spinal deformity will be defined as any coronal or sagittal plane spinal deformity in patients who have not undergone any previous spinal surgery (with the exception of prior decompression of a maximum of 2 levels) necessitating at a minimum a 5-level spinal fusion procedure. Standard radiographs and cross sectional imaging will be performed preoperatively, postoperatively, at 24 months and 5 years after surgery. Preoperative disease specific and general health questionnaires will be completed by all patients (EQ-5D, ODI, SRS-22r, NRS for back and leg pain). Follow up visits with questionnaires will be performed at 10 weeks (± 6 weeks), 12 months (± 2 months), 24 months (± 2 months) and 5 years (±6 months) post-operatively. All treatment-related AEs will be documented.

Regression analyses will be used to evaluate the association between patient demographics, comorbidities, treatment history, spinal deformity characteristics, surgical characteristics, treatment-related AEs and pre-surgical status to self-reported and radiographic outcomes after surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 60 years or older at the time of surgery
  • Diagnosis of adult spinal deformity either in the coronal or sagittal plane requiring at the minimum a 5-level spinal fusion procedure
  • Ability to understand the content of the patient information / Informed Consent Form
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated Institutional Review Board (IRB)/Ethics Committee (EC)-approved written informed consent
  • Reconsent of patients for the 5 year follow-up if required by the IRB/EC

Exclusion criteria

  • Any previous spinal procedure (except prior decompression of a maximum of 2 levels)
  • Neurodegenerative disease or paralysis
  • Unlikely to comply with follow-up
  • Institutionalized individuals
  • Any not medically managed severe systemic disease
  • Recent history (≤ 3 months) of substance abuse (ie, recreational drugs, alcohol) or psychosocial disturbance that would preclude reliable assessment
  • Prisoner
  • Presence of active malignancy
  • Has active, overt bacterial infection, systemic or local
  • History of recent(≤ 3 months) fracture/malignancy in the spinal region
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Treatment and study plan

Primary outcomes

  1. Absolute change in the Scoliosis Research Society-22 r (SRS-22r) total score

    Time frame: Baseline, 10 weeks, 12 months, 24 months

    The primary outcome is the absolute change in the SRS-22r total score between baseline and 24-months follow-up (FU) values in patients at age 60 or older treated with major spinal reconstruction.

    The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

Secondary outcomes

  1. Treatment-related adverse events

    Time frame: Surgery, 10 weeks, 12 months, 24 months, 5 years

  2. Oswestry Disability Index Version 2.1a (ODI)

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

    The outcome measure is the absolute change between baseline, the 24-month and the 5-year FU values.

    The ODI is a patient-reported outcome measure used most commonly in patients with low back pain. It consists of 10 questions and each of the items can be scored from 0 (no disability) to 5 (maximal disability), leading to a maximum score of 50.

  3. EuroQoL5 (EQ-5D).

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

    The EQ-5D is a standardized instrument designed for self-completion to assess quality of life. It has 5 items with a three-point categorical response scale. A unique EQ-5D health state is defined by combining one level from each of the five dimensions.

    The EQ-5D is a standardized instrument designed for self-completion to assess quality of life. It has 5 items with a three-point categorical response scale. A unique EQ-5D health state is defined by combining one level from each of the five dimensions.

  4. Pain (back and pain)

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

    The outcome measure is the absolute change between baseline,the 24-month and 5 year FU values.

    Lower back and leg pain will be assessed on a visual analogue scale (NRS) which ranges from 0 (no pain) to 100 (severe pain).

  5. Bone Mineral Density (BMD)

    Time frame: Baseline

    Baseline dual energy x-ray absorptiometry (DXA) scans of patients' BMD will only be performed at clinics where assessed as standard of care.

  6. Radiological Parameters

    Time frame: Baseline, Surgery, 24 months, 5 years

    Radiological paramaters (lumbar lordosis, thoracic kyphosis, sagittal vertical axis, Cobb angle) will be measured at one pre- and two post-OP timepoints from sagittal standing and coronal standing x-rays.

  7. Animal Fluency Test

    Time frame: Baseline, 10 weeks, 12 months, 24 months, 5 years

    The animal fluency test is a diagnostic tool that is recommended for use in clinical practice for quick assessment of cognitive impairment. The patient names as many animals as possible within a 60-second time period. Fifteen or fewer animals may indicate development of cognitive impairment.

  8. SRS-22r

    Time frame: 5 years

    The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

Sponsors and collaborators

Lead sponsor

AO Foundation, AO Spine

Other

Collaborators

  • AO Innovation Translation Center

Registry information

Official study title

Prospective Evaluation of Elderly Deformity Surgery: A Prospective Observational, Multicenter Study

Important dates

Study start
2013
Primary completion
2021
Study completion
2022
First posted
Jan 14, 2014
Registry last updated
Jul 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.